Hemoptysis
| Procedure | Appropriateness Category | Relative Radiation Level |
| Radiography chest | Usually Appropriate | ☢ |
| Arteriography bronchial with embolization | Usually Appropriate | ☢☢☢☢ |
| CT chest with IV contrast | Usually Appropriate | ☢☢☢ |
| CTA chest with IV contrast | Usually Appropriate | ☢☢☢ |
| CT chest without IV contrast | May Be Appropriate | ☢☢☢ |
| CT chest without and with IV contrast | Usually Not Appropriate | ☢☢☢ |
| Procedure | Appropriateness Category | Relative Radiation Level |
| Radiography chest | Usually Appropriate | ☢ |
| CT chest with IV contrast | Usually Appropriate | ☢☢☢ |
| CTA chest with IV contrast | Usually Appropriate | ☢☢☢ |
| Arteriography bronchial with embolization | May Be Appropriate | ☢☢☢☢ |
| CT chest without IV contrast | May Be Appropriate | ☢☢☢ |
| CT chest without and with IV contrast | Usually Not Appropriate | ☢☢☢ |
| Procedure | Appropriateness Category | Relative Radiation Level |
| Radiography chest | Usually Appropriate | ☢ |
| Arteriography bronchial with embolization | Usually Appropriate | ☢☢☢☢ |
| CTA chest with IV contrast | Usually Appropriate | ☢☢☢ |
| CT chest with IV contrast | May Be Appropriate | ☢☢☢ |
| CT chest without and with IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT chest without IV contrast | Usually Not Appropriate | ☢☢☢ |
Initial imaging is defined as imaging at the beginning of the care episode for the medical condition defined by the variant. More than one procedure can be considered usually appropriate in the initial imaging evaluation when:
- There are procedures that are equivalent alternatives (i.e., only one procedure will be ordered to provide the clinical information to effectively manage the patient’s care)
OR
- There are complementary procedures (i.e., more than one procedure is ordered as a set or simultaneously wherein each procedure provides unique clinical information to effectively manage the patient’s care).
A. Arteriography Bronchial with Embolization
B. CT Chest with IV Contrast
C. CT Chest without IV Contrast
D. CT Chest without and with IV Contrast
E. CTA Chest
F. Radiography Chest
A. Arteriography Bronchial with Embolization
B. CT Chest with IV Contrast
C. CT Chest without IV Contrast
D. CT Chest without and with IV Contrast
E. CTA Chest
F. Radiography Chest
A. Arteriography Bronchial with Embolization
B. CT Chest with IV Contrast
C. CT Chest without IV Contrast
D. CT Chest without and with IV Contrast
E. CTA Chest
F. Radiography Chest
The evidence table, literature search, and appendix for this topic are available at https://acsearch.acr.org/list. The appendix includes the strength of evidence assessment and the final rating round tabulations for each recommendation.
For additional information on the Appropriateness Criteria methodology and other supporting documents, please go to the ACR website at https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Appropriateness-Criteria.
|
Appropriateness Category Name |
Appropriateness Rating |
Appropriateness Category Definition |
|
Usually Appropriate |
7, 8, or 9 |
The imaging procedure or treatment is indicated in the specified clinical scenarios at a favorable risk-benefit ratio for patients. |
|
May Be Appropriate |
4, 5, or 6 |
The imaging procedure or treatment may be indicated in the specified clinical scenarios as an alternative to imaging procedures or treatments with a more favorable risk-benefit ratio, or the risk-benefit ratio for patients is equivocal. |
|
May Be Appropriate (Disagreement) |
5 |
The individual ratings are too dispersed from the panel median. The different label provides transparency regarding the panel’s recommendation. “May be appropriate” is the rating category and a rating of 5 is assigned. |
|
Usually Not Appropriate |
1, 2, or 3 |
The imaging procedure or treatment is unlikely to be indicated in the specified clinical scenarios, or the risk-benefit ratio for patients is likely to be unfavorable. |
Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, because of both organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared with those specified for adults (see Table below). Additional information regarding radiation dose assessment for imaging examinations can be found in the ACR Appropriateness Criteria® Radiation Dose Assessment Introduction document.
|
Relative Radiation Level Designations |
||
|
Relative Radiation Level* |
Adult Effective Dose Estimate Range |
Pediatric Effective Dose Estimate Range |
|
O |
0 mSv |
0 mSv |
|
☢ |
<0.1 mSv |
<0.03 mSv |
|
☢☢ |
0.1-1 mSv |
0.03-0.3 mSv |
|
☢☢☢ |
1-10 mSv |
0.3-3 mSv |
|
☢☢☢☢ |
10-30 mSv |
3-10 mSv |
|
☢☢☢☢☢ |
30-100 mSv |
10-30 mSv |
|
*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as “Varies.” |
||
| 1. | Jones R, Charlton J, Latinovic R, Gulliford MC. Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ. 339:b3094, 2009 Aug 13. | |
| 2. | Abdulmalak C, Cottenet J, Beltramo G, et al. Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative database. Eur Respir J. 46(2):503-11, 2015 Aug. | |
| 3. | Fartoukh M, Khalil A, Louis L, et al. An integrated approach to diagnosis and management of severe haemoptysis in patients admitted to the intensive care unit: a case series from a referral centre. Respir Res. 8:11, 2007 Feb 15. | |
| 4. | Tom LM, Palevsky HI, Holsclaw DS, et al. Recurrent Bleeding, Survival, and Longitudinal Pulmonary Function following Bronchial Artery Embolization for Hemoptysis in a U.S. Adult Population. J Vasc Interv Radiol. 26(12):1806-13.e1, 2015 Dec. | |
| 5. | Panda A, Bhalla AS, Goyal A. Bronchial artery embolization in hemoptysis: a systematic review. [Review]. Diagnostic & Interventional Radiology. 23(4):307-317, 2017 Jul-Aug. | |
| 6. | Sakr L, Dutau H. Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management. [Review]. Respiration. 80(1):38-58, 2010. | |
| 7. | Uzun O, Atasoy Y, Findik S, Atici AG, Erkan L. A prospective evaluation of hemoptysis cases in a tertiary referral hospital. The clinical respiratory journal. 4(3):131-8, 2010 Jul. | |
| 8. | Kervancioglu S, Bayram N, Gelebek Yilmaz F, Sanli M, Sirikci A. Radiological findings and outcomes of bronchial artery embolization in cryptogenic hemoptysis. J Korean Med Sci. 30(5):591-7, 2015 May. | |
| 9. | Ibrahim WH.. Massive haemoptysis: the definition should be revised. European Respiratory Journal. 32(4):1131-2, 2008 Oct. | |
| 10. | Lee MK, Kim SH, Yong SJ, et al. Moderate hemoptysis: recurrent hemoptysis and mortality according to bronchial artery embolization. Clin Respir J. 9(1):53-64, 2015 Jan. | |
| 11. | American College of Radiology. ACR–NASCI–SIR–SPR Practice Parameter for the Performance and Interpretation of Body Computed Tomography Angiography (CTA). Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=164+&releaseId=2. | |
| 12. | Fartoukh M, Khoshnood B, Parrot A, et al. Early prediction of in-hospital mortality of patients with hemoptysis: an approach to defining severe hemoptysis. Respiration. 83(2):106-14, 2012. | |
| 13. | Sopko DR, Smith TP. Bronchial artery embolization for hemoptysis. Semin Intervent Radiol 2011;28:48-62. | |
| 14. | Pei R, Zhou Y, Wang G, et al. Outcomes of bronchial artery embolization for life-threatening hemoptysis secondary to tuberculosis. PLoS ONE. 9(12):e115956, 2014. | |
| 15. | Bhalla A, Kandasamy D, Veedu P, Mohan A, Gamanagatti S. A retrospective analysis of 334 cases of hemoptysis treated by bronchial artery embolization. Oman Medical Journal. 30(2):119-28, 2015 Mar. | |
| 16. | Shao H, Wu J, Wu Q, et al. Bronchial artery embolization for hemoptysis: a retrospective observational study of 344 patients. Chin Med J. 128(1):58-62, 2015 Jan 05. | |
| 17. | Agmy GM, Wafy SM, Mohamed SAA, Gad YA, Mustafa H, Abd El-Aziz AE-S. Bronchial and Nonbronchial Systemic Artery Embolization in Management of Hemoptysis: Experience with 348 Patients. ISRN Vascular Medicine 2013;2013:1-7. | |
| 18. | Woo S, Yoon CJ, Chung JW, et al. Bronchial artery embolization to control hemoptysis: comparison of N-butyl-2-cyanoacrylate and polyvinyl alcohol particles. Radiology. 269(2):594-602, 2013 Nov. | |
| 19. | Shin BS, Jeon GS, Lee SA, Park MH. Bronchial artery embolisation for the management of haemoptysis in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 15(8):1093-8, 2011 Aug. | |
| 20. | Mehta AS, Ahmed O, Jilani D, et al. Bronchial artery embolization for malignant hemoptysis: a single institutional experience. Journal of Thoracic Disease. 7(8):1406-13, 2015 Aug. | |
| 21. | Razazi K, Parrot A, Khalil A, et al. Severe haemoptysis in patients with nonsmall cell lung carcinoma. Eur Respir J. 45(3):756-64, 2015 Mar. | |
| 22. | Delage A, Tillie-Leblond I, Cavestri B, Wallaert B, Marquette CH. Cryptogenic hemoptysis in chronic obstructive pulmonary disease: characteristics and outcome. Respiration. 80(5):387-92, 2010. | |
| 23. | Sbano H, Mitchell AW, Ind PW, Jackson JE. Peripheral pulmonary artery pseudoaneurysms and massive hemoptysis. AJR Am J Roentgenol. 184(4):1253-9, 2005 Apr. | |
| 24. | Shin TB, Yoon SK, Lee KN, et al. The role of pulmonary CT angiography and selective pulmonary angiography in endovascular management of pulmonary artery pseudoaneurysms associated with infectious lung diseases. J Vasc Interv Radiol. 18(7):882-7, 2007 Jul. | |
| 25. | Khalil A, Parrot A, Nedelcu C, Fartoukh M, Marsault C, Carette MF. Severe hemoptysis of pulmonary arterial origin: signs and role of multidetector row CT angiography. Chest. 133(1):212-9, 2008 Jan. | |
| 26. | Shin S, Shin TB, Choi H, et al. Peripheral pulmonary arterial pseudoaneurysms: therapeutic implications of endovascular treatment and angiographic classifications. Radiology. 256(2):656-64, 2010 Aug. | |
| 27. | Naidich DP, Funt S, Ettenger NA, Arranda C. Hemoptysis: CT-bronchoscopic correlations in 58 cases. Radiology. 1990; 177(2):357-362. | |
| 28. | Revel MP, Fournier LS, Hennebicque AS, et al. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol. 2002; 179(5):1217-1224. | |
| 29. | Dabo H, Gomes R, Marinho A, Madureira M, Paquete J, Morgado P. Bronchial artery embolisation in management of hemoptysis--A retrospective analysis in a tertiary university hospital. Rev Port Pneumol (Barc). 22(1):34-8, 2016 Jan-Feb. | |
| 30. | Yoon YC, Lee KS, Jeong YJ, Shin SW, Chung MJ, Kwon OJ. Hemoptysis: bronchial and nonbronchial systemic arteries at 16-detector row CT. Radiology. 234(1):292-8, 2005 Jan. | |
| 31. | Seon HJ, Kim YH, Kwon YS. Localization of bleeding sites in patients with hemoptysis based on their chest computed tomography findings: a retrospective cohort study. BMC polm. med.. 16(1):160, 2016 11 25. | |
| 32. | Tsoumakidou M, Chrysofakis G, Tsiligianni I, Maltezakis G, Siafakas NM, Tzanakis N. A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy. Respiration. 73(6):808-14, 2006. | |
| 33. | Khalil A, Fartoukh M, Parrot A, Bazelly B, Marsault C, Carette MF. Impact of MDCT angiography on the management of patients with hemoptysis. AJR Am J Roentgenol. 195(3):772-8, 2010 Sep. | |
| 34. | Remy-Jardin M, Bouaziz N, Dumont P, Brillet PY, Bruzzi J, Remy J. Bronchial and nonbronchial systemic arteries at multi-detector row CT angiography: comparison with conventional angiography. Radiology. 233(3):741-9, 2004 Dec. | |
| 35. | Hartmann IJ, Remy-Jardin M, Menchini L, Teisseire A, Khalil C, Remy J. Ectopic origin of bronchial arteries: assessment with multidetector helical CT angiography. Eur Radiol. 17(8):1943-53, 2007 Aug. | |
| 36. | Mori H, Ohno Y, Tsuge Y, et al. Use of multidetector row CT to evaluate the need for bronchial arterial embolization in hemoptysis patients. Respiration. 80(1):24-31, 2010. | |
| 37. | Jiang S, Sun XW, Yu D, Jie B. Endovascular embolization of bronchial artery originating from the upper portion of aortic arch in patients with massive hemoptysis. Cardiovasc Intervent Radiol. 37(1):94-100, 2014 Feb. | |
| 38. | Lin Y, Chen Z, Yang X, et al. Bronchial and non-bronchial systemic arteries: value of multidetector CT angiography in diagnosis and angiographic embolisation feasibility analysis. J Med Imaging Radiat Oncol. 57(6):644-51, 2013 Dec. | |
| 39. | Lee S, Chan JW, Chan SC, et al. Bronchial artery embolisation can be equally safe and effective in the management of chronic recurrent haemoptysis. HONG KONG MED. J.. 14(1):14-20, 2008 Feb. | |
| 40. | Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol. 177(4):861-7, 2001 Oct. | |
| 41. | Serasli E, Kalpakidis V, Iatrou K, Tsara V, Siopi D, Christaki P. Percutaneous bronchial artery embolization in the management of massive hemoptysis in chronic lung diseases. Immediate and long-term outcomes. Int Angiol. 27(4):319-28, 2008 Aug. | |
| 42. | O'Neil KM, Lazarus AA. Hemoptysis. Indications for bronchoscopy. Arch Intern Med. 1991; 151(1):171-174. | |
| 43. | Poe RH, Israel RH, Marin MG, et al. Utility of fiberoptic bronchoscopy in patients with hemoptysis and a nonlocalizing chest roentgenogram. Chest. 1988; 93(1):70-75. | |
| 44. | Thirumaran M, Sundar R, Sutcliffe IM, Currie DC. Is investigation of patients with haemoptysis and normal chest radiograph justified? Thorax. 2009; 64(10):854-856. | |
| 45. | Fujita T, Tanabe M, Moritani K, Matsunaga N, Matsumoto T. Immediate and late outcomes of bronchial and systemic artery embolization for palliative treatment of patients with nonsmall-cell lung cancer having hemoptysis. Am J Hosp Palliat Care. 31(6):602-7, 2014 Sep. | |
| 46. | Dave BR, Sharma A, Kalva SP, Wicky S. Nine-year single-center experience with transcatheter arterial embolization for hemoptysis: medium-term outcomes. Vasc Endovascular Surg. 2011; 45(3):258-268. | |
| 47. | Ishikawa H, Hara M, Ryuge M, et al. Efficacy and safety of super selective bronchial artery coil embolisation for haemoptysis: a single-centre retrospective observational study. BMJ Open. 7(2):e014805, 2017 Feb 17. | |
| 48. | Ando T, Kawashima M, Masuda K, et al. Clinical and Angiographic Characteristics of 35 Patients With Cryptogenic Hemoptysis. Chest. 152(5):1008-1014, 2017 Nov. | |
| 49. | Lee BR, Yu JY, Ban HJ, et al. Analysis of patients with hemoptysis in a tertiary referral hospital. Tuberc Respir Dis (Seoul). 73(2):107-14, 2012 Aug. | |
| 50. | Racil H, Rajhi H, Ben Naceur R, Chabbou A, Bouecha H, Mnif N. Endovascular treatment of haemoptysis: medium and long-term assessment. Diagn Interv Imaging. 94(1):38-44, 2013 Jan. | |
| 51. | Shin B, Koh WJ, Shin SW, et al. Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis in Patients with Chronic Pulmonary Aspergillosis. PLoS ONE. 11(12):e0168373, 2016. | |
| 52. | Yoo DH, Yoon CJ, Kang SG, Burke CT, Lee JH, Lee CT. Bronchial and nonbronchial systemic artery embolization in patients with major hemoptysis: safety and efficacy of N-butyl cyanoacrylate. AJR Am J Roentgenol. 196(2):W199-204, 2011 Feb. | |
| 53. | Hwang HG, Lee HS, Choi JS, Seo KH, Kim YH, Na JO. Risk factors influencing rebleeding after bronchial artery embolization on the management of hemoptysis associated with pulmonary tuberculosis. Tuberc Respir Dis (Seoul). 74(3):111-9, 2013 Mar. | |
| 54. | Kim SW, Lee SJ, Ryu YJ, et al. Prognosis and Predictors of Rebleeding After Bronchial Artery Embolization in Patients with Active or Inactive Pulmonary Tuberculosis. Lung. 193(4):575-81, 2015 Aug. | |
| 55. | Okuda K, Masuda K, Kawashima M, et al. Bronchial artery embolization to control hemoptysis in patients with Mycobacterium avium complex. Respir Investig. 54(1):50-8, 2016 Jan. | |
| 56. | Garcia-Olive I, Sanz-Santos J, Centeno C, et al. Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm. J Vasc Interv Radiol. 25(2):221-8, 2014 Feb. | |
| 57. | Wang GR, Ensor JE, Gupta S, Hicks ME, Tam AL. Bronchial artery embolization for the management of hemoptysis in oncology patients: utility and prognostic factors. J Vasc Interv Radiol. 20(6):722-9, 2009 Jun. | |
| 58. | Garcia-Olive I, Sanz-Santos J, Centeno C, et al. Predictors of recanalization in patients with life-threatening hemoptysis requiring artery embolization. Arch Bronconeumol. 50(2):51-6, 2014 Feb. | |
| 59. | Vidal V, Therasse E, Berthiaume Y, et al. Bronchial artery embolization in adults with cystic fibrosis: impact on the clinical course and survival. J Vasc Interv Radiol. 17(6):953-8, 2006 Jun. | |
| 60. | Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med. 182(3):298-306, 2010 Aug 01. | |
| 61. | Zhao T, Wang S, Zheng L, et al. The Value of 320-Row Multidetector CT Bronchial Arteriography in Recurrent Hemoptysis after Failed Transcatheter Arterial Embolization. J Vasc Interv Radiol. 28(4):533-541.e1, 2017 Apr. | |
| 62. | American College of Radiology. ACR Appropriateness Criteria® Radiation Dose Assessment Introduction. Available at: https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Appropriateness-Criteria/ACR-Appropriateness-Criteria-Radiation-Dose-Assessment-Introduction.pdf. |
The ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient’s clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient’s condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the FDA have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.